Literature DB >> 8422240

Induction of apoptosis by hemorrhagic snake venom in vascular endothelial cells.

S Araki1, T Ishida, T Yamamoto, K Kaji, H Hayashi.   

Abstract

Vascular degeneration appears to play crucial roles in producing many vascular malfunctions (1-3). In order to identify specific inducers of programmed death in vascular endothelial cells (VEC), examinations were made of the effects of substances that are known to affect the vascular system by using VEC in culture (4,5). We found that hemorrhagic snake venoms induced apoptotic cell death or programmed cell death of VEC. By contrast, neurotoxic snake venoms did not induce programmed cell death but caused necrosis at much higher doses of the venoms. No effect of hemorrhagic venom was observed with many types of cultured cells other than VEC. Thus, hemorrhagic snake venom appears to be a useful tool for studies of the molecular mechanisms of vascular apoptosis. The results also suggest a possible mechanism of action of hemorrhagic snake venom on the vascular system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8422240     DOI: 10.1006/bbrc.1993.1023

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Crystallization and preliminary X-ray crystallographic analysis of two vascular apoptosis-inducing proteins (VAPs) from Crotalus atrox venom.

Authors:  Tomoko Igarashi; Yuko Oishi; Satohiko Araki; Hidezo Mori; Soichi Takeda
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-06-26

2.  Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis.

Authors:  A Shimizu; H Kitamura; Y Masuda; M Ishizaki; Y Sugisaki; N Yamanaka
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

3.  In vitro analysis of venom from the wasp Nasonia vitripennis: susceptibility of different cell lines and venom-induced changes in plasma membrane permeability.

Authors:  D B Rivers; M Genco; R A Sanchez
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-02       Impact factor: 2.416

4.  Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB.

Authors:  A Z Badrichani; D M Stroka; G Bilbao; D T Curiel; F H Bach; C Ferran
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

Review 5.  Antitumoral activity of snake venom proteins: new trends in cancer therapy.

Authors:  Leonardo A Calderon; Juliana C Sobrinho; Kayena D Zaqueo; Andrea A de Moura; Amy N Grabner; Maurício V Mazzi; Silvana Marcussi; Auro Nomizo; Carla F C Fernandes; Juliana P Zuliani; Bruna M A Carvalho; Saulo L da Silva; Rodrigo G Stábeli; Andreimar M Soares
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411

6.  Induction of Apoptosis in Human Leukemia Cell Line (HL60) by Animal's Venom Derived Peptides (ICD-85).

Authors:  Abbas Zare Mirakabadi; Zahra Shahramyar; Hasan Morovvati; Mohsen Lotfi; Ali Nouri
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

Review 7.  Snake Venoms in Cancer Therapy: Past, Present and Future.

Authors:  Li Li; Jianzhong Huang; Yao Lin
Journal:  Toxins (Basel)       Date:  2018-08-29       Impact factor: 4.546

8.  Antitumor effect of Bothrops jararaca venom.

Authors:  Reinaldo J da Silva; Márcia G da Silva; Lízia C Vilela; Denise Fecchio
Journal:  Mediators Inflamm       Date:  2002-04       Impact factor: 4.711

9.  The effects of selected Australian snake venoms on tumour-associated microvascular endothelial cells (TAMECs) in vitro.

Authors:  Emma Bateman; Michael Venning; Peter Mirtschin; Anthony Woods
Journal:  J Venom Res       Date:  2013-10-19

Review 10.  Snake venom L-amino acid oxidases: an overview on their antitumor effects.

Authors:  Tássia R Costa; Sandra M Burin; Danilo L Menaldo; Fabíola A de Castro; Suely V Sampaio
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-06-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.